Poster Abstract Session:
044. Clinical Mycology
Thursday, October 5, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Risk Predictive Model for 90-Day Mortality in Candida Bloodstream Infections
Charlotte Lin, MD; Alyssa Kronen, B.A.; Kevin Hsueh, MD; William G. Powderly, MD, FIDSA; Andrej Spec, MD
Time Trends in the Burden of Hospitalizations with Invasive Aspergillosis in the US, 2004-2013
Marya D. Zilberberg, MD, MPH; Rachel Harrington, BA; James Spalding, PharmD, MS, MBA; Andrew F. Shorr, MD, MPH
β-d-glucan Testing is Overused in Patients Without Solid Organ/Stem Cell Transplant or Hematologic Malignancies.
Theodore Markou, MD; Valeria Fabre, MD; Seema Mehta, MD, MS; Shmuel Shoham, MD; Sara E. Cosgrove, MD, MS
Risk Factors and Mortality Associated with Candida krusei Bloodstream Infections
Ryan Kronen, B.A.; Charlotte Lin, MD; Kevin Hsueh, MD; William G. Powderly, MD, FIDSA; Andrej Spec, MD
  • IDweek poster final.pdf (1.3 MB)
  • 151
    Risk Factors Predicting Candida glabrata Bloodstream Infection
    Jane O'Halloran, MD PhD; Ryan Kronen, B.A.; Charlotte Lin, MD; Kevin Hsueh, MD; William G. Powderly, MD, FIDSA; Andrej Spec, MD
    Primary or Secondary Prophylaxis with Voriconazole Compared to Posaconazole for Prevention of Invasive Fungal Infections after Hematopoietic Stem Cell Transplantation
    Jeffrey W. Jansen, Pharm.D.; Anupam Pande, MD, MPH; Rizwan Romee, MD; Steven J. Lawrence, M.D., M.Sc.; William G. Powderly, MD, FIDSA
    Posaconazole Induced Hypertension and Hypokalemia: Mechanistic Evaluation
    George R. Thompson, MD; Diana Chang, MD; Rebecca Wittenberg, PharmD; Ian Mchardy, PhD; Alison Semrad, MD
    Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis
    Thein Myint, MBBS; Karen Bloch, MD, MPH, FIDSA; Luke Raymond-Guillen, MD; L. Joseph Wheat, MD, FIDSA
  • CNS BDG poster_final 09-23.pdf (323.4 kB)
  • 156
    Real-world experience of Voriconazole Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients – A Single Center Study
    Shuk-Ying Chan, MRCP(UK), FHKCP, FHKAM (Medicine); Dionysios Neofytos, MD, MPH; Rachel M. Hughes, BS; Yao-Ting Huang, PhD, MPH; Miguel-Angel Perales, MD; Genovefa Papanicolaou, MD
  • ID Week_VCZ.pdf (157.5 kB)
  • 157
    Natural History of Non-CNS Disseminated Coccidioidomycosis
    Derek Bays, MD; George R. Thompson, MD; Susan Reef, MD; Linda Snyder, MD; Milton Huppert, MD; David Salkin, MD; John Galgiani, MD
    Presentation and outcome of Cryptococcal infection varies by predisposing illness
    Krunal Raval, MD; William G. Powderly, MD, FIDSA; Andrej Spec, MD
    Antifungal Resistance Patterns in Molds Isolated from Wounds of Combat-Related Trauma Patients
    Nicholas Keaton, MD; Katrin Mende, PhD; Miriam Beckius, MPH; Aaron Farmer, DO; Julie Rizzo, MD; Anuradha Ganesan, MD, MPH; Clinton K. Murray, MD, FIDSA; David R. Tribble, MD, DrPH, FIDSA; Dana M. Blyth, MD
    Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children
    Emmanuel Roilides, MD, PhD; Fabianne Carlesse, MD; Heidi Leister-Tebbe, BSN; Umberto Conte, PharmD; Jean Li Yan, MS; Ping Liu, PhD; Margaret Tawadrous, MD; Jalal Aram, MD; Flavio Queiroz-Telles, MD, PhD
  • IDWeek_Roilides_ePoster 161.pdf (123.3 kB)
  • 162
    Invasive Mold Infections (IMIs) of the Central Nervous System (CNS) in patients (pts) with hematologic cancer (HC) (2000-2016): Uncommon but deadly
    Minas Platon Economides, MD; Leomar Ballester, MD; Vince Kumar, MD; Ying Jiang, MS; Jeffrey J. Tarrand, MD, MS; Victor Prieto, MD; Harrys Torres, M.D.; Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), FACP, FIDSA, FECMM, FAAM
  • CNS Mold Poster ID Week.pdf (374.1 kB)
  • 165
    Outcomes Comparing Initial Short versus Long Course Echinocandin Therapy in Patients with Candidemia Caused by Fluconazole Susceptible Strains
    Jennifer L. Small-Saunders, MD, PhD; Angela Loo, PharmD BCPS (AQ-ID); Deborah Theodore, MD; Amrita Singh, PharmD; Magdalena Sobieszczyk, MD, MPH; Christine J. Kubin, PharmD BCPS (AQ-ID)
    Breakthrough Invasive Candidiasis in Children
    Sara Dong, MD; Stella Antonara, PhD; Joseph Stanek, MS; Monica I. Ardura, DO, MSCS
  • Slide1.JPG (3.2 MB)
  • 167
    Comparing Diagnostic Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy
    Rita Wilson Dib, MD; Anne-Marie Chaftari, MD; Fady Ghaly, MD; Ying Jiang, MS; Ray Y. Hachem, MD; Issam Raad, MD
    Disseminated Coccidioidomycosis Among Children in Central California: A Retrospective Review
    Fouzia Naeem, MD, MS; Mohammad Nael Mhaissen, MD; James McCarty, MD; Chokechai Rongkavilit, MD
    Real-World Use – Isavuconazole at a Large Academic Medical Center
    Habiba Hassouna, MD; Kyle Brizendine, MD; Vasilios Athans, PharmD
    Epidemiology and Clinical Features of Invasive Fungal Disease in a U.S. Healthcare Network
    Brandon Webb, MD; Jeffrey Ferraro, PhD; Susan Rea, PhD, BSN; Jennifer Kammerer, PharmD, MS; Stephanie Kaufusi, BS; Bruce Goodman, BS; Greta Martin, MHE; James Spalding, PharmD, MS, MBA
    QTc Prolongation in Patients Receiving Triazoles and Amiodarone
    Katherine Cook, PharmD, MSCR; Thitinan Sraubol, PharmD, MSCR; Kristen Bova Campbell, PharmD, BCPS (AQ Cardiology), CPP, AACC; Ahmad Mourad, MD; Jonathan Stiber, MD; John R Perfect, M.D., FIDSA; Melissa Johnson, PharmD, MHS
    Epidemiology and Prognostic Factors of Non-albicans Candida species Candidemia: A Multicenter Study
    Yu-Lin Lee, M.D.; Chun-Eng Liu, M.D.; Szu-Han Lin, M.D.; I-Lun Hou, R.N.; Huei-Wen Lai, R.N.; Fu-Der Wang, M.D., PhD; Yin-Ching Chuang, M.D., PhD; Wei-Lun Liu, M.D.
    Ocular Candidiasis in Patients with Candidemia at a Large Tertiary Care Center
    Bonny Lee, MD; Lydia Breskin, MS; Laya Reddy, MD; Alessandro Iliceto, BLA; Deborah Ashcraft, BS; George Pankey, MD, FIDSA; Jonathan Nussdorf, MD; Julia Garcia-Diaz, MD, FIDSA
    The Risk Factors and the Characteristics of Fungal Endophthalmitis Following Candida Blood Stream Infection, a Case-control Study
    Hideaki Kato, MD; Kayoko Sano, MT; Yoshifumi Sugiyama, MT; Risa Sakai, MD; Sei Samukawa, MD; Hideaki Nakajima, MD, PhD
    Antifungal Resistance and Predictors of Response in Patients with Hematologic Malignancy
    Shiuan (Shannon) Wey, PharmD, PhD; Jane Kriengkauykiat, PharmD; Ayla Chan, PharmD; Bernard Tegtmeier, PhD; James Ito, MD; Sanjeet Dadwal, MD
    Candida parapsilosis Candidemia Resistance Patterns and Treatment Outcomes: an Opportunity for Antifungal Stewardship
    Gary Fong, PharmD; Kim Ngo, PharmD; Hannah Russo, PharmD; Nicholas Beyda, PharmD
    Phaeohyphomycosis: A Ten-Year Review (2006-2016)
    Varun Sundaramoorthy, General Medicine; Frederico Duarte, General Medicine; Promila Mohan Raj, M.Sc, PhD; Joy S Michael, MD, FRC(Path); Priscilla Rupali, MD
  • IMG_5201.JPG (216.3 kB)
  • 181
    Clinical Outcomes of the Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections
    Gregory B. Tallman, PharmD; Jon P. Furuno, PhD; Brie N. Noble, BS; Joseph S. Bubalo, PharmD; Graeme N. Forrest, MBBS, FIDSA; James Lewis, PharmD, FIDSA; Ana F. Bienvenida, BS; Courtney A. Holmes, BS; Bo R. Weber, BS; Jessina C. McGregor, PhD
  • IDWeek 2017 Poster FINAL.pdf (255.3 kB)
  • 182
    Clinical Characteristics and Outcomes in Hospitalized Patients with Proven and Probable Coccidioidomycosis at the National Institute of Respiratory Diseases in Mexico City.
    Jose Arturo Martinez-Orozco, MD; Angelina Contreras-Cortez, MD; Fernando Morales-Villareal, Ch.; Eduardo Becerril Vargas, MD
  • poster cocci ID week.pdf (676.4 kB)
  • 183
    Do Liver Transplant Recipients Have a Higher Risk for Cryptococcosis Than Non-liver Transplant Recipients?
    Hsin-Yun Sun, MD; Aristine Cheng, MD; Cheng-Maw Ho, MD; Rey-Heng Hu, M.D.; Nai-Kuan Chou, M.D.; Shoei-Shen Wang, M.D.; Yee-Chun Chen, M.D., Ph.D.; Shan-Chwen Chang, M.D., PhD
  • 183 SOT Crypto.pdf (699.8 kB)
  • 184
    Review of Treatment Regimens for Mucormycosis in a Las Vegas County Hospital Between 2013-2017
    Angela Villamagna, M.D.; Ian Adrian Frani, B.S.N., M.D.; Kimberly D. Leuthner, PharmD, FIDSA; Shadaba Asad, MD
  • Mucor Poster Final Draft.pdf (1.7 MB)
  • 185
    The trends in the distribution of Candida species causing candidemia at a community hospital in 2005 and 2014.
    Celestine Ishiekwene, MBBS, MBA; Maxine Seales Kasangana, MD; Monica Ghitan, MD, FIDSA; Margaret Kuhn-Basti, M.D.; Edward Chapnick, MD, FIDSA, FSHEA; Yu Shia Lin, MD
  • Candida IDWEEK (2).pdf (598.6 kB)
  • 186
    Epidemiology of Invasive Fungal Disease by Aspergillus in a University Hospital in Santiago - Chile, During the Period 2005-2015
    Pablo Valenzuela, Fellow; Ricardo Rabagliati, Physician; Paulette Legarraga, Physician
  • POSTER IDWEEK 2017.pdf (305.7 kB)
  • 187
    Candidemia with ocular manifestrations: a review of 26 cases in a university hospital in Japan
    Tohru Takata, MD, PhD; Yoshinobu Yoshimura, MD, PhD; Yumiko Obata, MD; Atsushi Togawa, MD, PhD; Yasushi Takamatsu, MD, PhD
    Epidemiology, Risk factors and Outcomes of Candida Empyema: A 5-year Single Centered Experience
    Jonathan Williams, MD; Odaliz Abreu Lanfranco, MD; Juan Lemos-Ramirez, MD; Pallavi Bhargava, MD; George Alangaden, MD, FIDSA; Mayur Ramesh, MD
    Epidemiology and Outcomes of Hospitalizations with Invasive Aspergillosis in the US, 2010-2013
    Marya D. Zilberberg, MD, MPH; Brian Nathanson, PhD; Rachel Harrington, BA; James Spalding, PharmD, MS, MBA; Andrew F. Shorr, MD, MPH
    Epidemiology and Risk Factors for Antifungal Resistance in Patients with Candidemia
    Namareq Aldardeer, Pharm.D; Hadeil Albar, MD; Majda Alattas, Pharm.D; Mohammed Qutub, PhD; Basem Alraddadi, MD, MSc
    Improved Survival of Candida CLABSI by Adherence to Standard of Care and Involvement of Infectious Diseases Consultant: A 5-year Experience in a Single Academic Center
    Blessy John, MD; Maricar Malinis, MD, FACP, FIDSA; Iyanna Fairweather, Infection Preventionist; Michael Aniskiewicz, M(ASCP), CIC; Jose Rivera- Vinas, Data Analysis Specialist; Robert Baltimore, MD, FIDSA, FSHEA, FPIDS; Richard Martinello, MD
    Treatment Bundle Improves Outcomes in the Management of Candidemia at Large Urban Academic Medical Center
    Gregory Cook, PharmD; Shreena Advani, PharmD; Saira Rab, PharmD; Sheetal Kandiah, MD MPH; Manish Patel, PharmD; Jordan Wong, PharmD
  • CTB ID Week Poster_final.pdf (777.2 kB)
  • 193
    Validation of an Empiric Candidemia Treatment Algorithm
    Conor M. Stack, MD; Lovisa B. Olafsdottir, MD; Monica V. Mahoney, PharmD, BCPS-AQ ID; Christopher McCoy, PharmD, BCPS-AQ ID; Howard S. Gold, MD, FIDSA; Mary Lasalvia, MD, MPH; David S Yassa, MD; Sharon B Wright, MD, MPH, FIDSA, FSHEA; Graham M. Snyder, MD, SM

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.